Plain-English translation of NCT07032389 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
After a heart attack, doctors prescribe multiple medications to prevent future heart problems. This trial is testing whether a polypill—a single combination pill that contains aspirin, rosuvastatin, and either prasugrel or clopidogrel—works just as well as taking these three medications as separate pills. The goal is to make treatment simpler and safer for heart attack survivors.
Heart attack survivors face a high risk of another heart attack or complications in the first month after discharge, even with current treatments. Doctors hope that by combining three essential medications into one pill, patients will be more likely to take their medications regularly and correctly, which could prevent future heart problems.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either take the combination pill once daily or continue taking three separate pills as usual. You'll be followed for 12 months, during which the research team will monitor how well the treatment works and check for any side effects. Your participation will help doctors understand whether this simpler approach is as safe and effective as the current standard treatment.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
United States